Reducing expression of NAD+ synthesizing enzyme NMNAT1 does not affect the rate of Wallerian degeneration
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Reducing expression of NAD+ synthesizing enzyme NMNAT1 does not affect the rate of Wallerian degeneration
Authors
Keywords
-
Journal
FEBS Journal
Volume 278, Issue 15, Pages 2666-2679
Publisher
Wiley
Online
2011-05-26
DOI
10.1111/j.1742-4658.2011.08193.x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Wallerian Degeneration, WldS, and Nmnat
- (2010) Michael P. Coleman et al. Annual Review of Neuroscience
- Unique expression pattern of human nicotinamide mononucleotide adenylyltransferase isozymes in red blood cells
- (2010) M. Di Stefano et al. BLOOD CELLS MOLECULES AND DISEASES
- Isoform-specific Targeting and Interaction Domains in Human Nicotinamide Mononucleotide Adenylyltransferases
- (2010) Corinna Lau et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Axonal Degeneration Is Blocked by Nicotinamide Mononucleotide Adenylyltransferase (Nmnat) Protein Transduction into Transected Axons
- (2010) Yo Sasaki et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Targeting NMNAT1 to Axons and Synapses Transforms Its Neuroprotective Potency In Vivo
- (2010) E. Babetto et al. JOURNAL OF NEUROSCIENCE
- NAD+ Depletion Is Necessary and Sufficient forPoly(ADP-Ribose) Polymerase-1-Mediated Neuronal Death
- (2010) C. C. Alano et al. JOURNAL OF NEUROSCIENCE
- Endogenous Nmnat2 Is an Essential Survival Factor for Maintenance of Healthy Axons
- (2010) Jonathan Gilley et al. PLOS BIOLOGY
- Evolutionary divergence of valosin-containing protein/cell division cycle protein 48 binding interactions among endoplasmic reticulum-associated degradation proteins
- (2009) Giacomo Morreale et al. FEBS Journal
- Enzymes in the NAD+Salvage Pathway Regulate SIRT1 Activity at Target Gene Promoters
- (2009) Tong Zhang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- WldSrequires Nmnat1 enzymatic activity and N16–VCP interactions to suppress Wallerian degeneration
- (2009) Michelle A. Avery et al. JOURNAL OF CELL BIOLOGY
- WldSprotein requires Nmnat activity and a short N-terminal sequence to protect axons in mice
- (2009) Laura Conforti et al. JOURNAL OF CELL BIOLOGY
- Axonal and Cell Body Protection By Nicotinamide Adenine Dinucleotide in Tumor Necrosis Factor-Induced Optic Neuropathy
- (2009) Yasushi Kitaoka et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Non-Nuclear WldS Determines Its Neuroprotective Efficacy for Axons and Synapses In Vivo
- (2009) B. Beirowski et al. JOURNAL OF NEUROSCIENCE
- Transgenic Mice Expressing the Nmnat1 Protein Manifest Robust Delay in Axonal Degeneration In Vivo
- (2009) Y. Sasaki et al. JOURNAL OF NEUROSCIENCE
- Nicotinamide Mononucleotide Adenylyl Transferase-Mediated Axonal Protection Requires Enzymatic Activity But Not Increased Levels of Neuronal Nicotinamide Adenine Dinucleotide
- (2009) Y. Sasaki et al. JOURNAL OF NEUROSCIENCE
- Metabolism control by the circadian clock and vice versa
- (2009) Kristin Eckel-Mahan et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Nicotinamide Prevents NAD+ Depletion and Protects Neurons Against Excitotoxicity and Cerebral Ischemia: NAD+ Consumption by SIRT1 may Endanger Energetically Compromised Neurons
- (2009) Dong Liu et al. NEUROMOLECULAR MEDICINE
- Circadian Control of the NAD+ Salvage Pathway by CLOCK-SIRT1
- (2009) Y. Nakahata et al. SCIENCE
- Circadian Clock Feedback Cycle Through NAMPT-Mediated NAD+ Biosynthesis
- (2009) K. M. Ramsey et al. SCIENCE
- Emerging Roles of NAD+ and Its Metabolites in Cell Signaling
- (2009) F. Koch-Nolte et al. Science Signaling
- Characterization of NAD Uptake in Mammalian Cells
- (2008) Richard A. Billington et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- NAD synthase NMNAT acts as a chaperone to protect against neurodegeneration
- (2008) R. Grace Zhai et al. NATURE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started